Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
1 (download XLSX Statistical source data
In a recent FDA drug safety communication regarding SGLT-2 inhibitor-associated DKA, hypovolemia and acute renal impairment were listed as potential factors that may contribute to the development of a high anion gap metabolic acidosis
During your initial consultation, your healthcare provider will review your medical history, current medications, and any underlying health conditions
The key difference lies in how they are formulated, dosed, and marketed
Economic Burden of Stroke in Iran: a Population-based study
US$ 22.11
US$ 25.87
US$ 21.58
US$ 20.43
US$ 25.89
